Proteina Co., Ltd.
KOSDAQTotal Valuation
Proteina Co., Ltd. carries a market capitalization of 272.39B, placing it among publicly traded companies globally. Its enterprise value stands at 657.56B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 272.39B |
| Enterprise Value | 657.56B |
Valuation Ratios
The price-to-sales ratio is 329.43, and the price-to-book ratio stands at -9.03.
| PE Ratio | N/A |
| PS Ratio | 329.43 |
| PB Ratio | -9.03 |
| P/TBV Ratio | 27.48 |
| P/FCF Ratio | -94.21 |
| P/OCF Ratio | -75.27 |
Enterprise Valuation
| EV / Sales | 319.57 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Proteina Co., Ltd. maintains a current ratio of 15.79, meaning it holds 15.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.16, indicating elevated leverage, while an interest coverage ratio of -182.14 demonstrates limited ability to service its debt obligations.
| Current Ratio | 15.79 |
| Quick Ratio | 14.02 |
| Debt / Equity | 3.16 |
| Debt / EBITDA | -0.06 |
| Interest Coverage | -182.14 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -48.06 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.35 |
Stock Price Statistics
Proteina Co., Ltd.'s stock has gained approximately 41.88034% over the past 52 weeks. The 50-day moving average sits at 41,806.00, while the 200-day moving average is 64,976.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | 41.88034% |
| 50-Day Moving Average | 41,806.00 |
| 200-Day Moving Average | 64,976.25 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Proteina Co., Ltd. generated 2.06B in revenue and converted that into -10.85B in net income, yielding earnings per share of -1,065.56. EBITDA reached -14.50B, while operating income came in at -14.50B.
| Revenue | 2.06B |
| Gross Profit | 889.38M |
| Operating Income | -14.50B |
| Pretax Income | -10.85B |
| Net Income | -10.85B |
| EBITDA | -14.50B |
| EBIT | -14.50B |
| Earnings Per Share (EPS) | -1,065.56 |
Balance Sheet
Proteina Co., Ltd. holds 21.08B in cash and equivalents against 798.20M in total debt, resulting in a net debt position of -3.89B. Total book value stands at -75.07B, with working capital of 22.25B providing operational flexibility.
| Cash & Cash Equivalents | 21.08B |
| Total Debt | 798.20M |
| Net Debt | -3.89B |
| Equity (Book Value) | -75.07B |
| Book Value Per Share | -7,375.67 |
| Working Capital | 22.25B |
Cash Flow
Proteina Co., Ltd. produced -9.01B in operating cash flow over the past twelve months. After subtracting -1.81B in capital expenditures, free cash flow totaled -10.82B - equivalent to -1,062.81 per share.
| Operating Cash Flow | -9.01B |
| Capital Expenditures | -1.81B |
| Free Cash Flow | -10.82B |
| FCF Per Share | -1,062.81 |
Margins
Proteina Co., Ltd. operates with a gross margin of 43.22, reflecting its pricing power and cost economics. The operating margin of -704.91 and net profit margin of -527.07 provide insight into operational efficiency.
| Gross Margin | 43.22 |
| Operating Margin | -704.91 |
| Pretax Margin | -527.07 |
| Profit Margin | -527.07 |
| EBITDA Margin | -704.91 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -3.11 |
| FCF Yield | -1.06 |
Scores
Proteina Co., Ltd. posts an Altman Z-Score of 112.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 112.90 |